Waterdrop operates in China’s healthcare market, positioning itself as a provider of medical alternatives. The company focuses on delivering non-traditional medical solutions, aiming to broaden healthcare options for Chinese consumers. While detailed operating metrics such as revenue or user counts were not disclosed, Waterdrop’s ability to attract a major technology investor underscores market confidence in its model. Tencent’s leadership of the latest financing signals strong strategic backing. The recent Series B injection of capital is expected to bolster the company’s expansion and product development. Waterdrop’s growing capital base indicates increasing momentum in a sector that is attracting heightened investor interest.

Total raised

$445M

Funding rounds

3

Latest round

Series D

Latest activity

Aug 2020